Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

PLS Group shares closed at A$4.12 Friday, down 1.2% after a 3.7% drop Thursday. Morgan Stanley and Mitsubishi UFJ Financial Group disclosed increased voting power in the lithium miner, both citing changes dated Feb. 2. The moves came as lithium prices fell and Australian equities posted their sharpest drop in months. PLS reports interim results Feb. 19.
Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

Commonwealth Bank of Australia shares closed at A$158.91, down 0.23% Friday, as the S&P/ASX 200 fell 2.03% and nearly A$70 billion was wiped from the market. The bank reports half-year results and an interim dividend on Feb. 11, with shares going ex-dividend Feb. 18. CBA flagged a A$68 million provision linked to ASIC’s Better Banking review. The RBA raised rates to 3.85% on Feb. 3, with CBA passing on the increase from Feb. 13.
NAB share price drops as ASX selloff spooks bank stocks — what to watch before Monday

NAB share price drops as ASX selloff spooks bank stocks — what to watch before Monday

NAB shares fell 1.57% to A$43.36 as Australian stocks slumped Friday, with the ASX 200 down 2% and all sectors in the red. The bank will raise variable home loan rates by 25 basis points from Feb. 13 after the RBA’s latest hike. Investors await NAB’s first-quarter update on Feb. 18 for signs of stress in margins and credit.
CSL share price in focus after ASX sell-off: what investors watch before Feb 11 results

CSL share price in focus after ASX sell-off: what investors watch before Feb 11 results

CSL Limited shares closed down 0.4% at A$180.50 Friday as the S&P/ASX 200 dropped 2.03% to 8,708.80. CSL will report half-year results and announce its interim dividend on Feb. 11, with the stock set to trade ex-dividend March 10. A filing showed 59,992 CSL conditional rights lapsed this week. The company’s market value stands near A$87 billion, down about a third in the past year.
WiseTech Global share price slides to A$47.60 as AI fears batter ASX tech — what to watch next

WiseTech Global share price slides to A$47.60 as AI fears batter ASX tech — what to watch next

WiseTech Global shares fell 4.6% to A$47.60 Friday, with turnover at 3.61 million shares, amid a broader selloff in software stocks. The S&P/ASX 200 dropped 2.03%, its worst session since November, and WiseTech is down 28.7% for the month. U.S. software stocks have lost about $1 trillion since Jan. 28. WiseTech’s half-year results are due Feb. 25.
Macquarie Group share price slips 2% after APRA eases liquidity curbs — what to watch next week

Macquarie Group share price slips 2% after APRA eases liquidity curbs — what to watch next week

Macquarie Group shares fell 2.17% to A$207.83 Friday, marking a third straight decline as the ASX 200 slid 2%. Australia’s regulator trimmed liquidity requirements for Macquarie Bank after improvements in controls. Macquarie Asset Management announced two UK utility deals, including full ownership of Last Mile Infrastructure and the purchase of Energy Assets Group. Investors await Tuesday’s operational briefing.
Adaptive Biotechnologies (ADPT) stock swings after earnings as MRD guidance, insider sale draw scrutiny

Adaptive Biotechnologies (ADPT) stock swings after earnings as MRD guidance, insider sale draw scrutiny

Adaptive Biotechnologies shares fell 5.2% to $15.61 Friday after Q4 revenue jumped 51% to $71.7 million and the company forecast 2026 MRD revenue of $255–$265 million. CEO Chad Robins disclosed selling 124,998 shares on Feb. 2. BTIG raised its price target to $22. The stock traded between $17.69 and $15.08 during the session.
Haemonetics stock slides 7% as revenue dip and hospital softness blunt raised outlook

Haemonetics stock slides 7% as revenue dip and hospital softness blunt raised outlook

Haemonetics shares dropped 7% Friday to $60.46 despite the company raising its full-year profit and cash flow outlook. Third-quarter revenue fell 2.7% to $339 million, while adjusted EPS rose to $1.31. Interventional technology revenue declined 12%, offsetting a 3% gain in plasma. Citigroup cut its price target to $75.
Werner Enterprises stock skids nearly 8% after Q4 loss and $44 mln one-way overhaul — what’s next for WERN

Werner Enterprises stock skids nearly 8% after Q4 loss and $44 mln one-way overhaul — what’s next for WERN

Werner Enterprises shares fell 7.9% to $34.87 after posting a $27.8 million Q4 loss, citing restructuring charges. Revenue dropped 2% to $737.6 million. The company forecast 23%-28% average truck-count growth for 2026 with the FirstFleet acquisition. Total debt rose to $752 million at year-end, with borrowings increasing after the deal closed.
Dow Hits 50,000 as Nvidia Jumps and Amazon’s $200B AI Capex Plan Whipsaws Markets

Dow Hits 50,000 as Nvidia Jumps and Amazon’s $200B AI Capex Plan Whipsaws Markets

The Dow Jones Industrial Average closed above 50,000 for the first time Friday, rising 2.24% to 50,005.78, led by gains in Nvidia and Caterpillar. The S&P 500 climbed 1.73% and the Nasdaq rose 1.91%. Amazon and Alphabet’s plans for record AI spending unsettled markets earlier in the week but investors returned to tech stocks. Bitcoin, gold, and oil prices held steady after Thursday’s selloff.

Stock Market Today

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

7 February 2026
Amazon shares fell Friday after the company announced a $200 billion AI infrastructure plan for 2026, exceeding analyst expectations and reviving investor concerns about profitability. Combined 2026 capex flagged by Amazon, Alphabet, Microsoft, and Meta now tops $630 billion. Nvidia, AMD, and Broadcom shares surged on the news, while software and data firms remained under pressure.
Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

7 February 2026
Nvidia surged 7.8% Friday, leading a chip stock rally that pushed the Dow above 50,000 for the first time. The PHLX semiconductor index gained 5.7% as Advanced Micro Devices rose 8.3% and Broadcom 7.1%. Amazon fell 5.6% after projecting $200 billion in 2026 capital spending. Investors weighed a $600 billion AI infrastructure outlay against sharp losses in software shares.
Go toTop